nodes	percent_of_prediction	percent_of_DWPC	metapath
Miconazole—CYP1A2—Imiquimod—skin cancer	0.0792	0.117	CbGbCtD
Miconazole—CYP2C19—Vismodegib—skin cancer	0.0595	0.0882	CbGbCtD
Miconazole—CYP2E1—Dacarbazine—skin cancer	0.0575	0.0852	CbGbCtD
Miconazole—CYP2A6—Fluorouracil—skin cancer	0.0511	0.0757	CbGbCtD
Miconazole—CYP2C9—Vismodegib—skin cancer	0.0495	0.0733	CbGbCtD
Miconazole—ABCB1—Vismodegib—skin cancer	0.048	0.0711	CbGbCtD
Miconazole—CYP1A2—Vemurafenib—skin cancer	0.0434	0.0643	CbGbCtD
Miconazole—CYP3A4—Imiquimod—skin cancer	0.0415	0.0615	CbGbCtD
Miconazole—CYP3A4—Temozolomide—skin cancer	0.0415	0.0615	CbGbCtD
Miconazole—CYP2D6—Vemurafenib—skin cancer	0.0358	0.053	CbGbCtD
Miconazole—CYP1A2—Dacarbazine—skin cancer	0.0333	0.0493	CbGbCtD
Miconazole—CYP3A4—Vismodegib—skin cancer	0.0288	0.0426	CbGbCtD
Miconazole—ABCB1—Dactinomycin—skin cancer	0.0252	0.0374	CbGbCtD
Miconazole—CYP3A4—Vemurafenib—skin cancer	0.0227	0.0337	CbGbCtD
Miconazole—CYP1A2—Fluorouracil—skin cancer	0.0195	0.0289	CbGbCtD
Miconazole—CYP2C9—Fluorouracil—skin cancer	0.0176	0.026	CbGbCtD
Miconazole—ABCB1—Docetaxel—skin cancer	0.013	0.0193	CbGbCtD
Miconazole—KCNMB1—blood vessel—skin cancer	0.00982	0.0781	CbGeAlD
Miconazole—NOS3—penis—skin cancer	0.0086	0.0684	CbGeAlD
Miconazole—CYP3A4—Docetaxel—skin cancer	0.0078	0.0116	CbGbCtD
Miconazole—Instillation site pain—Imiquimod—skin cancer	0.00691	0.037	CcSEcCtD
Miconazole—NOS3—hindlimb—skin cancer	0.0065	0.0516	CbGeAlD
Miconazole—NOS3—appendage—skin cancer	0.00557	0.0443	CbGeAlD
Miconazole—Ageusia—Vismodegib—skin cancer	0.00528	0.0283	CcSEcCtD
Miconazole—Application site pain—Imiquimod—skin cancer	0.00512	0.0274	CcSEcCtD
Miconazole—KCNMB2—epithelium—skin cancer	0.00453	0.036	CbGeAlD
Miconazole—KCNMB3—lymphoid tissue—skin cancer	0.00379	0.0302	CbGeAlD
Miconazole—KCNMB3—female reproductive system—skin cancer	0.00366	0.0291	CbGeAlD
Miconazole—Allergic contact dermatitis—Fluorouracil—skin cancer	0.00356	0.0191	CcSEcCtD
Miconazole—KCNMB1—female reproductive system—skin cancer	0.00355	0.0282	CbGeAlD
Miconazole—Tooth disorder—Imiquimod—skin cancer	0.00347	0.0186	CcSEcCtD
Miconazole—KCNMB2—female reproductive system—skin cancer	0.00337	0.0268	CbGeAlD
Miconazole—NOS3—endothelium—skin cancer	0.00336	0.0267	CbGeAlD
Miconazole—Gamma-glutamyltransferase increased—Vemurafenib—skin cancer	0.00321	0.0172	CcSEcCtD
Miconazole—NOS3—blood vessel—skin cancer	0.0031	0.0246	CbGeAlD
Miconazole—KCNN2—skin of body—skin cancer	0.00308	0.0245	CbGeAlD
Miconazole—KCNMB3—head—skin cancer	0.00306	0.0243	CbGeAlD
Miconazole—KCNMB1—head—skin cancer	0.00297	0.0236	CbGeAlD
Miconazole—Abdominal pain upper—Vismodegib—skin cancer	0.00284	0.0152	CcSEcCtD
Miconazole—Application site pain—Fluorouracil—skin cancer	0.00283	0.0152	CcSEcCtD
Miconazole—KCNMA1—blood vessel—skin cancer	0.0027	0.0215	CbGeAlD
Miconazole—Lymphopenia—Temozolomide—skin cancer	0.00264	0.0141	CcSEcCtD
Miconazole—KCNN4—nipple—skin cancer	0.00256	0.0203	CbGeAlD
Miconazole—KCNN3—head—skin cancer	0.00243	0.0193	CbGeAlD
Miconazole—KCNN2—female reproductive system—skin cancer	0.00241	0.0191	CbGeAlD
Miconazole—KCNMB4—head—skin cancer	0.00232	0.0184	CbGeAlD
Miconazole—NOS3—neck—skin cancer	0.00222	0.0176	CbGeAlD
Miconazole—KCNMB3—lymph node—skin cancer	0.00214	0.017	CbGeAlD
Miconazole—Tooth disorder—Temozolomide—skin cancer	0.00208	0.0112	CcSEcCtD
Miconazole—KCNN2—head—skin cancer	0.00201	0.016	CbGeAlD
Miconazole—KCNH7—head—skin cancer	0.00191	0.0152	CbGeAlD
Miconazole—Dysgeusia—Vismodegib—skin cancer	0.00183	0.00981	CcSEcCtD
Miconazole—Muscle spasms—Vismodegib—skin cancer	0.0018	0.00963	CcSEcCtD
Miconazole—Lymphopenia—Docetaxel—skin cancer	0.00175	0.0094	CcSEcCtD
Miconazole—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00173	0.00925	CcSEcCtD
Miconazole—KCNN4—epithelium—skin cancer	0.00172	0.0137	CbGeAlD
Miconazole—KCNN3—lymph node—skin cancer	0.0017	0.0135	CbGeAlD
Miconazole—Gamma-glutamyltransferase increased—Temozolomide—skin cancer	0.00164	0.00879	CcSEcCtD
Miconazole—KCNH6—female reproductive system—skin cancer	0.00163	0.013	CbGeAlD
Miconazole—KCNMB4—lymph node—skin cancer	0.00162	0.0129	CbGeAlD
Miconazole—NOS3—connective tissue—skin cancer	0.00159	0.0126	CbGeAlD
Miconazole—NOS3—epithelium—skin cancer	0.00151	0.012	CbGeAlD
Miconazole—CYP17A1—connective tissue—skin cancer	0.0015	0.0119	CbGeAlD
Miconazole—Nervous system disorder—Vismodegib—skin cancer	0.0015	0.00802	CcSEcCtD
Miconazole—Infestation—Vemurafenib—skin cancer	0.00148	0.00792	CcSEcCtD
Miconazole—Infestation NOS—Vemurafenib—skin cancer	0.00148	0.00792	CcSEcCtD
Miconazole—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00147	0.00785	CcSEcCtD
Miconazole—KCNN2—lymph node—skin cancer	0.00141	0.0112	CbGeAlD
Miconazole—KCNH6—head—skin cancer	0.00136	0.0108	CbGeAlD
Miconazole—Mouth ulceration—Dactinomycin—skin cancer	0.00135	0.00723	CcSEcCtD
Miconazole—Decreased appetite—Vismodegib—skin cancer	0.00133	0.00711	CcSEcCtD
Miconazole—KCNN4—lymphoid tissue—skin cancer	0.00133	0.0105	CbGeAlD
Miconazole—Gastrointestinal disorder—Vismodegib—skin cancer	0.00132	0.00706	CcSEcCtD
Miconazole—KCNMA1—epithelium—skin cancer	0.00132	0.0105	CbGeAlD
Miconazole—Fatigue—Vismodegib—skin cancer	0.00132	0.00705	CcSEcCtD
Miconazole—Upper respiratory tract infection—Imiquimod—skin cancer	0.00131	0.00704	CcSEcCtD
Miconazole—Pain—Vismodegib—skin cancer	0.0013	0.00699	CcSEcCtD
Miconazole—KCNN4—female reproductive system—skin cancer	0.00128	0.0102	CbGeAlD
Miconazole—Infestation NOS—Imiquimod—skin cancer	0.00126	0.00675	CcSEcCtD
Miconazole—Infestation—Imiquimod—skin cancer	0.00126	0.00675	CcSEcCtD
Miconazole—Erythema multiforme—Vemurafenib—skin cancer	0.00125	0.00672	CcSEcCtD
Miconazole—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00125	0.0067	CcSEcCtD
Miconazole—Gastrointestinal pain—Vismodegib—skin cancer	0.00125	0.00669	CcSEcCtD
Miconazole—Dermatitis contact—Fluorouracil—skin cancer	0.00123	0.00659	CcSEcCtD
Miconazole—Abdominal pain—Vismodegib—skin cancer	0.00121	0.00646	CcSEcCtD
Miconazole—Mediastinal disorder—Vemurafenib—skin cancer	0.0012	0.00641	CcSEcCtD
Miconazole—Hepatobiliary disease—Imiquimod—skin cancer	0.00119	0.00639	CcSEcCtD
Miconazole—Chills—Vemurafenib—skin cancer	0.00119	0.00638	CcSEcCtD
Miconazole—NOS3—lymphoid tissue—skin cancer	0.00116	0.00924	CbGeAlD
Miconazole—Dysgeusia—Vemurafenib—skin cancer	0.00113	0.00606	CcSEcCtD
Miconazole—NOS3—female reproductive system—skin cancer	0.00112	0.00891	CbGeAlD
Miconazole—Ageusia—Docetaxel—skin cancer	0.00111	0.00594	CcSEcCtD
Miconazole—Gastroenteritis—Temozolomide—skin cancer	0.00111	0.00593	CcSEcCtD
Miconazole—Asthenia—Vismodegib—skin cancer	0.00109	0.00587	CcSEcCtD
Miconazole—Pruritus—Vismodegib—skin cancer	0.00108	0.00578	CcSEcCtD
Miconazole—Erythema multiforme—Imiquimod—skin cancer	0.00107	0.00573	CcSEcCtD
Miconazole—KCNN4—head—skin cancer	0.00107	0.00849	CbGeAlD
Miconazole—CYP17A1—female reproductive system—skin cancer	0.00106	0.00842	CbGeAlD
Miconazole—Diarrhoea—Vismodegib—skin cancer	0.00104	0.00559	CcSEcCtD
Miconazole—Immune system disorder—Imiquimod—skin cancer	0.00102	0.00548	CcSEcCtD
Miconazole—Mediastinal disorder—Imiquimod—skin cancer	0.00102	0.00546	CcSEcCtD
Miconazole—Chills—Imiquimod—skin cancer	0.00102	0.00544	CcSEcCtD
Miconazole—Cough—Vemurafenib—skin cancer	0.00101	0.0054	CcSEcCtD
Miconazole—KCNH2—nipple—skin cancer	0.001	0.00796	CbGeAlD
Miconazole—KCNMA1—female reproductive system—skin cancer	0.000978	0.00777	CbGeAlD
Miconazole—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.000976	0.00523	CcSEcCtD
Miconazole—Vomiting—Vismodegib—skin cancer	0.00097	0.0052	CcSEcCtD
Miconazole—Rash—Vismodegib—skin cancer	0.000962	0.00515	CcSEcCtD
Miconazole—Dermatitis—Vismodegib—skin cancer	0.000961	0.00515	CcSEcCtD
Miconazole—Anaphylactic shock—Vemurafenib—skin cancer	0.000943	0.00505	CcSEcCtD
Miconazole—NOS3—head—skin cancer	0.000937	0.00745	CbGeAlD
Miconazole—Infection—Vemurafenib—skin cancer	0.000936	0.00502	CcSEcCtD
Miconazole—Nervous system disorder—Vemurafenib—skin cancer	0.000924	0.00495	CcSEcCtD
Miconazole—Ill-defined disorder—Imiquimod—skin cancer	0.000914	0.0049	CcSEcCtD
Miconazole—CYP19A1—connective tissue—skin cancer	0.000908	0.00722	CbGeAlD
Miconazole—Nausea—Vismodegib—skin cancer	0.000906	0.00486	CcSEcCtD
Miconazole—Angioedema—Imiquimod—skin cancer	0.0009	0.00482	CcSEcCtD
Miconazole—Malaise—Imiquimod—skin cancer	0.000888	0.00476	CcSEcCtD
Miconazole—CYP17A1—head—skin cancer	0.000885	0.00704	CbGeAlD
Miconazole—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000883	0.00473	CcSEcCtD
Miconazole—Neutropenia—Dactinomycin—skin cancer	0.000876	0.00469	CcSEcCtD
Miconazole—Stomatitis—Bleomycin—skin cancer	0.000873	0.00468	CcSEcCtD
Miconazole—Cough—Imiquimod—skin cancer	0.000859	0.00461	CcSEcCtD
Miconazole—CYP1A2—nipple—skin cancer	0.000858	0.00682	CbGeAlD
Miconazole—Discomfort—Imiquimod—skin cancer	0.000828	0.00444	CcSEcCtD
Miconazole—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000828	0.00444	CcSEcCtD
Miconazole—Dry mouth—Imiquimod—skin cancer	0.00082	0.00439	CcSEcCtD
Miconazole—Decreased appetite—Vemurafenib—skin cancer	0.000819	0.00439	CcSEcCtD
Miconazole—KCNMA1—head—skin cancer	0.000817	0.00649	CbGeAlD
Miconazole—Stomatitis—Dactinomycin—skin cancer	0.000814	0.00436	CcSEcCtD
Miconazole—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000814	0.00436	CcSEcCtD
Miconazole—Fatigue—Vemurafenib—skin cancer	0.000813	0.00435	CcSEcCtD
Miconazole—Infection—Imiquimod—skin cancer	0.000799	0.00428	CcSEcCtD
Miconazole—Neutropenia—Temozolomide—skin cancer	0.000792	0.00424	CcSEcCtD
Miconazole—Nervous system disorder—Imiquimod—skin cancer	0.000788	0.00422	CcSEcCtD
Miconazole—Upper respiratory tract infection—Temozolomide—skin cancer	0.000787	0.00422	CcSEcCtD
Miconazole—Anorexia—Imiquimod—skin cancer	0.000766	0.00411	CcSEcCtD
Miconazole—Infestation NOS—Temozolomide—skin cancer	0.000755	0.00405	CcSEcCtD
Miconazole—Infestation—Temozolomide—skin cancer	0.000755	0.00405	CcSEcCtD
Miconazole—Hepatitis—Dactinomycin—skin cancer	0.00075	0.00402	CcSEcCtD
Miconazole—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000749	0.00401	CcSEcCtD
Miconazole—KCNN4—lymph node—skin cancer	0.000748	0.00595	CbGeAlD
Miconazole—Stomatitis—Temozolomide—skin cancer	0.000736	0.00395	CcSEcCtD
Miconazole—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000725	0.00389	CcSEcCtD
Miconazole—Chills—Bleomycin—skin cancer	0.000721	0.00386	CcSEcCtD
Miconazole—Hepatobiliary disease—Temozolomide—skin cancer	0.000714	0.00383	CcSEcCtD
Miconazole—Erythema multiforme—Dactinomycin—skin cancer	0.000709	0.0038	CcSEcCtD
Miconazole—Decreased appetite—Imiquimod—skin cancer	0.000699	0.00374	CcSEcCtD
Miconazole—Infestation—Fluorouracil—skin cancer	0.000696	0.00373	CcSEcCtD
Miconazole—Infestation NOS—Fluorouracil—skin cancer	0.000696	0.00373	CcSEcCtD
Miconazole—Hypersensitivity—Vemurafenib—skin cancer	0.000694	0.00372	CcSEcCtD
Miconazole—Gastrointestinal disorder—Imiquimod—skin cancer	0.000694	0.00372	CcSEcCtD
Miconazole—Fatigue—Imiquimod—skin cancer	0.000693	0.00371	CcSEcCtD
Miconazole—Pain—Imiquimod—skin cancer	0.000687	0.00368	CcSEcCtD
Miconazole—Stomatitis—Fluorouracil—skin cancer	0.000678	0.00363	CcSEcCtD
Miconazole—Hepatitis—Temozolomide—skin cancer	0.000678	0.00363	CcSEcCtD
Miconazole—Asthenia—Vemurafenib—skin cancer	0.000676	0.00362	CcSEcCtD
Miconazole—Chills—Dactinomycin—skin cancer	0.000673	0.0036	CcSEcCtD
Miconazole—Pruritus—Vemurafenib—skin cancer	0.000667	0.00357	CcSEcCtD
Miconazole—Feeling abnormal—Imiquimod—skin cancer	0.000662	0.00355	CcSEcCtD
Miconazole—Gastrointestinal pain—Imiquimod—skin cancer	0.000657	0.00352	CcSEcCtD
Miconazole—NOS3—lymph node—skin cancer	0.000656	0.00521	CbGeAlD
Miconazole—Ill-defined disorder—Bleomycin—skin cancer	0.000649	0.00348	CcSEcCtD
Miconazole—Anaemia—Bleomycin—skin cancer	0.000647	0.00347	CcSEcCtD
Miconazole—Diarrhoea—Vemurafenib—skin cancer	0.000645	0.00346	CcSEcCtD
Miconazole—Erythema multiforme—Temozolomide—skin cancer	0.000641	0.00344	CcSEcCtD
Miconazole—CYP19A1—female reproductive system—skin cancer	0.000641	0.00509	CbGeAlD
Miconazole—Urticaria—Imiquimod—skin cancer	0.000639	0.00342	CcSEcCtD
Miconazole—Abdominal pain—Imiquimod—skin cancer	0.000635	0.00341	CcSEcCtD
Miconazole—Malaise—Bleomycin—skin cancer	0.000631	0.00338	CcSEcCtD
Miconazole—CYP17A1—lymph node—skin cancer	0.00062	0.00493	CbGeAlD
Miconazole—Immune system disorder—Temozolomide—skin cancer	0.000612	0.00328	CcSEcCtD
Miconazole—Mediastinal disorder—Temozolomide—skin cancer	0.000611	0.00327	CcSEcCtD
Miconazole—Cough—Bleomycin—skin cancer	0.000611	0.00327	CcSEcCtD
Miconazole—Chills—Temozolomide—skin cancer	0.000608	0.00326	CcSEcCtD
Miconazole—ABCB1—blood vessel—skin cancer	0.000608	0.00483	CbGeAlD
Miconazole—Ill-defined disorder—Dactinomycin—skin cancer	0.000605	0.00324	CcSEcCtD
Miconazole—Anaemia—Dactinomycin—skin cancer	0.000603	0.00323	CcSEcCtD
Miconazole—Vomiting—Vemurafenib—skin cancer	0.000599	0.00321	CcSEcCtD
Miconazole—Abdominal pain upper—Docetaxel—skin cancer	0.000595	0.00319	CcSEcCtD
Miconazole—Rash—Vemurafenib—skin cancer	0.000594	0.00318	CcSEcCtD
Miconazole—Dermatitis—Vemurafenib—skin cancer	0.000594	0.00318	CcSEcCtD
Miconazole—Hypersensitivity—Imiquimod—skin cancer	0.000592	0.00317	CcSEcCtD
Miconazole—Headache—Vemurafenib—skin cancer	0.00059	0.00316	CcSEcCtD
Miconazole—Discomfort—Bleomycin—skin cancer	0.000589	0.00315	CcSEcCtD
Miconazole—Malaise—Dactinomycin—skin cancer	0.000588	0.00315	CcSEcCtD
Miconazole—Cramp muscle—Docetaxel—skin cancer	0.000587	0.00315	CcSEcCtD
Miconazole—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000587	0.00315	CcSEcCtD
Miconazole—Dysgeusia—Temozolomide—skin cancer	0.000578	0.0031	CcSEcCtD
Miconazole—Asthenia—Imiquimod—skin cancer	0.000577	0.00309	CcSEcCtD
Miconazole—KCNMA1—lymph node—skin cancer	0.000572	0.00455	CbGeAlD
Miconazole—Anaphylactic shock—Bleomycin—skin cancer	0.000571	0.00306	CcSEcCtD
Miconazole—Pruritus—Imiquimod—skin cancer	0.000569	0.00305	CcSEcCtD
Miconazole—Infection—Bleomycin—skin cancer	0.000567	0.00304	CcSEcCtD
Miconazole—Nausea—Vemurafenib—skin cancer	0.00056	0.003	CcSEcCtD
Miconazole—Diarrhoea—Imiquimod—skin cancer	0.00055	0.00295	CcSEcCtD
Miconazole—Discomfort—Dactinomycin—skin cancer	0.000549	0.00294	CcSEcCtD
Miconazole—Ill-defined disorder—Temozolomide—skin cancer	0.000548	0.00293	CcSEcCtD
Miconazole—Anaemia—Temozolomide—skin cancer	0.000546	0.00292	CcSEcCtD
Miconazole—Anorexia—Bleomycin—skin cancer	0.000544	0.00292	CcSEcCtD
Miconazole—Angioedema—Temozolomide—skin cancer	0.000539	0.00289	CcSEcCtD
Miconazole—CYP19A1—head—skin cancer	0.000535	0.00425	CbGeAlD
Miconazole—Malaise—Temozolomide—skin cancer	0.000532	0.00285	CcSEcCtD
Miconazole—Infection—Dactinomycin—skin cancer	0.000529	0.00284	CcSEcCtD
Miconazole—Neutropenia—Docetaxel—skin cancer	0.000527	0.00282	CcSEcCtD
Miconazole—CYP2B6—skin of body—skin cancer	0.000527	0.00419	CbGeAlD
Miconazole—Cough—Temozolomide—skin cancer	0.000515	0.00276	CcSEcCtD
Miconazole—Vomiting—Imiquimod—skin cancer	0.000511	0.00274	CcSEcCtD
Miconazole—Anorexia—Dactinomycin—skin cancer	0.000508	0.00272	CcSEcCtD
Miconazole—Rash—Imiquimod—skin cancer	0.000507	0.00272	CcSEcCtD
Miconazole—Dermatitis—Imiquimod—skin cancer	0.000506	0.00271	CcSEcCtD
Miconazole—Headache—Imiquimod—skin cancer	0.000504	0.0027	CcSEcCtD
Miconazole—Anaemia—Fluorouracil—skin cancer	0.000503	0.00269	CcSEcCtD
Miconazole—Infestation NOS—Docetaxel—skin cancer	0.000502	0.00269	CcSEcCtD
Miconazole—Infestation—Docetaxel—skin cancer	0.000502	0.00269	CcSEcCtD
Miconazole—KCNH2—female reproductive system—skin cancer	0.000501	0.00398	CbGeAlD
Miconazole—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000498	0.00267	CcSEcCtD
Miconazole—Discomfort—Temozolomide—skin cancer	0.000496	0.00266	CcSEcCtD
Miconazole—Decreased appetite—Bleomycin—skin cancer	0.000496	0.00266	CcSEcCtD
Miconazole—Dry mouth—Temozolomide—skin cancer	0.000491	0.00263	CcSEcCtD
Miconazole—Stomatitis—Docetaxel—skin cancer	0.00049	0.00262	CcSEcCtD
Miconazole—Pain—Bleomycin—skin cancer	0.000488	0.00262	CcSEcCtD
Miconazole—Anaphylactic shock—Temozolomide—skin cancer	0.000482	0.00258	CcSEcCtD
Miconazole—Infection—Temozolomide—skin cancer	0.000479	0.00256	CcSEcCtD
Miconazole—Nausea—Imiquimod—skin cancer	0.000477	0.00256	CcSEcCtD
Miconazole—Hepatobiliary disease—Docetaxel—skin cancer	0.000475	0.00255	CcSEcCtD
Miconazole—Nervous system disorder—Temozolomide—skin cancer	0.000472	0.00253	CcSEcCtD
Miconazole—Feeling abnormal—Bleomycin—skin cancer	0.000471	0.00252	CcSEcCtD
Miconazole—Decreased appetite—Dactinomycin—skin cancer	0.000463	0.00248	CcSEcCtD
Miconazole—Fatigue—Dactinomycin—skin cancer	0.000459	0.00246	CcSEcCtD
Miconazole—Anorexia—Temozolomide—skin cancer	0.000459	0.00246	CcSEcCtD
Miconazole—Discomfort—Fluorouracil—skin cancer	0.000457	0.00245	CcSEcCtD
Miconazole—Pain—Dactinomycin—skin cancer	0.000455	0.00244	CcSEcCtD
Miconazole—Urticaria—Bleomycin—skin cancer	0.000454	0.00243	CcSEcCtD
Miconazole—Hepatitis—Docetaxel—skin cancer	0.000451	0.00242	CcSEcCtD
Miconazole—Anaphylactic shock—Fluorouracil—skin cancer	0.000444	0.00238	CcSEcCtD
Miconazole—Infection—Fluorouracil—skin cancer	0.000441	0.00236	CcSEcCtD
Miconazole—Feeling abnormal—Dactinomycin—skin cancer	0.000439	0.00235	CcSEcCtD
Miconazole—Gastrointestinal pain—Dactinomycin—skin cancer	0.000435	0.00233	CcSEcCtD
Miconazole—Nervous system disorder—Fluorouracil—skin cancer	0.000435	0.00233	CcSEcCtD
Miconazole—CYP2B6—lymphoid tissue—skin cancer	0.000427	0.00339	CbGeAlD
Miconazole—Erythema multiforme—Docetaxel—skin cancer	0.000426	0.00228	CcSEcCtD
Miconazole—Anorexia—Fluorouracil—skin cancer	0.000423	0.00227	CcSEcCtD
Miconazole—Abdominal pain—Dactinomycin—skin cancer	0.000421	0.00226	CcSEcCtD
Miconazole—Hypersensitivity—Bleomycin—skin cancer	0.000421	0.00225	CcSEcCtD
Miconazole—KCNH2—head—skin cancer	0.000419	0.00333	CbGeAlD
Miconazole—Decreased appetite—Temozolomide—skin cancer	0.000419	0.00224	CcSEcCtD
Miconazole—Gastrointestinal disorder—Temozolomide—skin cancer	0.000416	0.00223	CcSEcCtD
Miconazole—Fatigue—Temozolomide—skin cancer	0.000415	0.00223	CcSEcCtD
Miconazole—Pain—Temozolomide—skin cancer	0.000412	0.00221	CcSEcCtD
Miconazole—CYP2B6—female reproductive system—skin cancer	0.000411	0.00327	CbGeAlD
Miconazole—Asthenia—Bleomycin—skin cancer	0.00041	0.0022	CcSEcCtD
Miconazole—CYP2C9—female reproductive system—skin cancer	0.000407	0.00324	CbGeAlD
Miconazole—Immune system disorder—Docetaxel—skin cancer	0.000407	0.00218	CcSEcCtD
Miconazole—Mediastinal disorder—Docetaxel—skin cancer	0.000406	0.00218	CcSEcCtD
Miconazole—Chills—Docetaxel—skin cancer	0.000405	0.00217	CcSEcCtD
Miconazole—Pruritus—Bleomycin—skin cancer	0.000404	0.00217	CcSEcCtD
Miconazole—CYP2E1—lymphoid tissue—skin cancer	0.0004	0.00318	CbGeAlD
Miconazole—Feeling abnormal—Temozolomide—skin cancer	0.000397	0.00213	CcSEcCtD
Miconazole—Gastrointestinal pain—Temozolomide—skin cancer	0.000394	0.00211	CcSEcCtD
Miconazole—Hypersensitivity—Dactinomycin—skin cancer	0.000392	0.0021	CcSEcCtD
Miconazole—CYP2E1—female reproductive system—skin cancer	0.000386	0.00307	CbGeAlD
Miconazole—Decreased appetite—Fluorouracil—skin cancer	0.000386	0.00207	CcSEcCtD
Miconazole—Dysgeusia—Docetaxel—skin cancer	0.000384	0.00206	CcSEcCtD
Miconazole—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000383	0.00205	CcSEcCtD
Miconazole—Urticaria—Temozolomide—skin cancer	0.000383	0.00205	CcSEcCtD
Miconazole—Asthenia—Dactinomycin—skin cancer	0.000382	0.00205	CcSEcCtD
Miconazole—Abdominal pain—Temozolomide—skin cancer	0.000381	0.00204	CcSEcCtD
Miconazole—Pain—Fluorouracil—skin cancer	0.00038	0.00203	CcSEcCtD
Miconazole—Muscle spasms—Docetaxel—skin cancer	0.000377	0.00202	CcSEcCtD
Miconazole—CYP19A1—lymph node—skin cancer	0.000375	0.00298	CbGeAlD
Miconazole—Feeling abnormal—Fluorouracil—skin cancer	0.000366	0.00196	CcSEcCtD
Miconazole—Diarrhoea—Dactinomycin—skin cancer	0.000364	0.00195	CcSEcCtD
Miconazole—Vomiting—Bleomycin—skin cancer	0.000363	0.00195	CcSEcCtD
Miconazole—Anaemia—Docetaxel—skin cancer	0.000363	0.00194	CcSEcCtD
Miconazole—Rash—Bleomycin—skin cancer	0.00036	0.00193	CcSEcCtD
Miconazole—Dermatitis—Bleomycin—skin cancer	0.00036	0.00193	CcSEcCtD
Miconazole—Hypersensitivity—Temozolomide—skin cancer	0.000355	0.0019	CcSEcCtD
Miconazole—Urticaria—Fluorouracil—skin cancer	0.000353	0.00189	CcSEcCtD
Miconazole—Asthenia—Temozolomide—skin cancer	0.000346	0.00185	CcSEcCtD
Miconazole—CYP2B6—head—skin cancer	0.000344	0.00273	CbGeAlD
Miconazole—Cough—Docetaxel—skin cancer	0.000343	0.00184	CcSEcCtD
Miconazole—Pruritus—Temozolomide—skin cancer	0.000341	0.00183	CcSEcCtD
Miconazole—Nausea—Bleomycin—skin cancer	0.000339	0.00182	CcSEcCtD
Miconazole—Vomiting—Dactinomycin—skin cancer	0.000339	0.00181	CcSEcCtD
Miconazole—Rash—Dactinomycin—skin cancer	0.000336	0.0018	CcSEcCtD
Miconazole—Diarrhoea—Temozolomide—skin cancer	0.00033	0.00177	CcSEcCtD
Miconazole—Hypersensitivity—Fluorouracil—skin cancer	0.000327	0.00175	CcSEcCtD
Miconazole—Dry mouth—Docetaxel—skin cancer	0.000327	0.00175	CcSEcCtD
Miconazole—CYP2E1—head—skin cancer	0.000323	0.00256	CbGeAlD
Miconazole—Anaphylactic shock—Docetaxel—skin cancer	0.00032	0.00172	CcSEcCtD
Miconazole—Infection—Docetaxel—skin cancer	0.000318	0.00171	CcSEcCtD
Miconazole—Nausea—Dactinomycin—skin cancer	0.000316	0.0017	CcSEcCtD
Miconazole—Nervous system disorder—Docetaxel—skin cancer	0.000314	0.00168	CcSEcCtD
Miconazole—Pruritus—Fluorouracil—skin cancer	0.000314	0.00168	CcSEcCtD
Miconazole—CYP3A4—female reproductive system—skin cancer	0.000311	0.00247	CbGeAlD
Miconazole—Vomiting—Temozolomide—skin cancer	0.000306	0.00164	CcSEcCtD
Miconazole—CYP2D6—female reproductive system—skin cancer	0.000306	0.00243	CbGeAlD
Miconazole—Anorexia—Docetaxel—skin cancer	0.000305	0.00164	CcSEcCtD
Miconazole—Rash—Temozolomide—skin cancer	0.000304	0.00163	CcSEcCtD
Miconazole—Diarrhoea—Fluorouracil—skin cancer	0.000304	0.00163	CcSEcCtD
Miconazole—Dermatitis—Temozolomide—skin cancer	0.000303	0.00163	CcSEcCtD
Miconazole—Headache—Temozolomide—skin cancer	0.000302	0.00162	CcSEcCtD
Miconazole—ABCB1—epithelium—skin cancer	0.000296	0.00235	CbGeAlD
Miconazole—KCNH2—lymph node—skin cancer	0.000293	0.00233	CbGeAlD
Miconazole—Nausea—Temozolomide—skin cancer	0.000286	0.00153	CcSEcCtD
Miconazole—Vomiting—Fluorouracil—skin cancer	0.000282	0.00151	CcSEcCtD
Miconazole—Rash—Fluorouracil—skin cancer	0.00028	0.0015	CcSEcCtD
Miconazole—Dermatitis—Fluorouracil—skin cancer	0.00028	0.0015	CcSEcCtD
Miconazole—Decreased appetite—Docetaxel—skin cancer	0.000278	0.00149	CcSEcCtD
Miconazole—Headache—Fluorouracil—skin cancer	0.000278	0.00149	CcSEcCtD
Miconazole—Gastrointestinal disorder—Docetaxel—skin cancer	0.000277	0.00148	CcSEcCtD
Miconazole—Fatigue—Docetaxel—skin cancer	0.000276	0.00148	CcSEcCtD
Miconazole—Pain—Docetaxel—skin cancer	0.000274	0.00147	CcSEcCtD
Miconazole—Feeling abnormal—Docetaxel—skin cancer	0.000264	0.00141	CcSEcCtD
Miconazole—Nausea—Fluorouracil—skin cancer	0.000264	0.00141	CcSEcCtD
Miconazole—Gastrointestinal pain—Docetaxel—skin cancer	0.000262	0.0014	CcSEcCtD
Miconazole—ABCB1—mammalian vulva—skin cancer	0.000257	0.00204	CbGeAlD
Miconazole—CYP2D6—head—skin cancer	0.000255	0.00203	CbGeAlD
Miconazole—Abdominal pain—Docetaxel—skin cancer	0.000253	0.00136	CcSEcCtD
Miconazole—Hypersensitivity—Docetaxel—skin cancer	0.000236	0.00126	CcSEcCtD
Miconazole—Asthenia—Docetaxel—skin cancer	0.00023	0.00123	CcSEcCtD
Miconazole—ABCB1—lymphoid tissue—skin cancer	0.000228	0.00181	CbGeAlD
Miconazole—Pruritus—Docetaxel—skin cancer	0.000227	0.00121	CcSEcCtD
Miconazole—ABCB1—female reproductive system—skin cancer	0.00022	0.00175	CbGeAlD
Miconazole—Diarrhoea—Docetaxel—skin cancer	0.000219	0.00117	CcSEcCtD
Miconazole—Vomiting—Docetaxel—skin cancer	0.000204	0.00109	CcSEcCtD
Miconazole—Rash—Docetaxel—skin cancer	0.000202	0.00108	CcSEcCtD
Miconazole—Dermatitis—Docetaxel—skin cancer	0.000202	0.00108	CcSEcCtD
Miconazole—Headache—Docetaxel—skin cancer	0.000201	0.00108	CcSEcCtD
Miconazole—Nausea—Docetaxel—skin cancer	0.00019	0.00102	CcSEcCtD
Miconazole—ABCB1—head—skin cancer	0.000184	0.00146	CbGeAlD
Miconazole—ABCB1—lymph node—skin cancer	0.000129	0.00102	CbGeAlD
Miconazole—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000108	0.00857	CbGpPWpGaD
Miconazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—skin cancer	0.000107	0.00854	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—skin cancer	0.000106	0.00844	CbGpPWpGaD
Miconazole—CYP2A6—Fluoropyrimidine Activity—ERCC2—skin cancer	0.0001	0.00798	CbGpPWpGaD
Miconazole—NOS3—EGF/EGFR Signaling Pathway—RASA1—skin cancer	9.88e-05	0.00785	CbGpPWpGaD
Miconazole—KCNMB2—Neuronal System—BRAF—skin cancer	9.7e-05	0.00771	CbGpPWpGaD
Miconazole—KCNMB3—Neuronal System—BRAF—skin cancer	9.7e-05	0.00771	CbGpPWpGaD
Miconazole—KCNMB4—Neuronal System—BRAF—skin cancer	9.7e-05	0.00771	CbGpPWpGaD
Miconazole—KCNMB1—Neuronal System—BRAF—skin cancer	9.7e-05	0.00771	CbGpPWpGaD
Miconazole—KCNN2—BDNF signaling pathway—HRAS—skin cancer	9.47e-05	0.00753	CbGpPWpGaD
Miconazole—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	9.04e-05	0.00719	CbGpPWpGaD
Miconazole—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—skin cancer	8.58e-05	0.00682	CbGpPWpGaD
Miconazole—KCNH7—Circadian rythm related genes—CDK4—skin cancer	8.18e-05	0.00651	CbGpPWpGaD
Miconazole—NOS3—EGF/EGFR Signaling Pathway—FOXO4—skin cancer	8.1e-05	0.00644	CbGpPWpGaD
Miconazole—NOS3—Plasma membrane estrogen receptor signaling—NRAS—skin cancer	8.08e-05	0.00643	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—CDK4—skin cancer	8.04e-05	0.00639	CbGpPWpGaD
Miconazole—NOS2—IL23-mediated signaling events—IL6—skin cancer	7.91e-05	0.00629	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	7.89e-05	0.00627	CbGpPWpGaD
Miconazole—CYP11B1—Corticotropin-releasing hormone—BRAF—skin cancer	7.28e-05	0.00579	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	7.17e-05	0.0057	CbGpPWpGaD
Miconazole—KCNN4—Neuronal System—BRAF—skin cancer	7.15e-05	0.00568	CbGpPWpGaD
Miconazole—NOS2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—skin cancer	7.03e-05	0.00559	CbGpPWpGaD
Miconazole—NOS3—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	6.96e-05	0.00553	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—MSH2—skin cancer	6.84e-05	0.00544	CbGpPWpGaD
Miconazole—NOS3—Corticotropin-releasing hormone—BRAF—skin cancer	6.74e-05	0.00536	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	6.71e-05	0.00533	CbGpPWpGaD
Miconazole—KCNN1—Neuronal System—HRAS—skin cancer	6.26e-05	0.00498	CbGpPWpGaD
Miconazole—KCNN3—Neuronal System—HRAS—skin cancer	6.26e-05	0.00498	CbGpPWpGaD
Miconazole—KCNH6—Neuronal System—BRAF—skin cancer	6.25e-05	0.00497	CbGpPWpGaD
Miconazole—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—skin cancer	6.14e-05	0.00489	CbGpPWpGaD
Miconazole—NOS3—SHP2 signaling—NRAS—skin cancer	6.13e-05	0.00487	CbGpPWpGaD
Miconazole—NOS2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—skin cancer	6.05e-05	0.00481	CbGpPWpGaD
Miconazole—NOS3—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	5.91e-05	0.0047	CbGpPWpGaD
Miconazole—KCNMA1—Circadian rythm related genes—CDK4—skin cancer	5.88e-05	0.00467	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—PTGS2—skin cancer	5.74e-05	0.00457	CbGpPWpGaD
Miconazole—KCNN2—Neuronal System—HRAS—skin cancer	5.58e-05	0.00443	CbGpPWpGaD
Miconazole—KCNH7—Neuronal System—BRAF—skin cancer	5.57e-05	0.00443	CbGpPWpGaD
Miconazole—NOS2—ATF-2 transcription factor network—IL6—skin cancer	5.45e-05	0.00433	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—RHOU—skin cancer	5.38e-05	0.00428	CbGpPWpGaD
Miconazole—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—skin cancer	5.38e-05	0.00428	CbGpPWpGaD
Miconazole—NOS3—SHP2 signaling—KRAS—skin cancer	5.27e-05	0.00419	CbGpPWpGaD
Miconazole—NOS2—Circadian rythm related genes—CDK4—skin cancer	5.25e-05	0.00417	CbGpPWpGaD
Miconazole—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—skin cancer	5.14e-05	0.00409	CbGpPWpGaD
Miconazole—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—skin cancer	4.91e-05	0.0039	CbGpPWpGaD
Miconazole—NOS3—SHP2 signaling—HRAS—skin cancer	4.48e-05	0.00356	CbGpPWpGaD
Miconazole—KCNMB3—Neuronal System—HRAS—skin cancer	4.46e-05	0.00355	CbGpPWpGaD
Miconazole—KCNMB4—Neuronal System—HRAS—skin cancer	4.46e-05	0.00355	CbGpPWpGaD
Miconazole—KCNMB2—Neuronal System—HRAS—skin cancer	4.46e-05	0.00355	CbGpPWpGaD
Miconazole—KCNMB1—Neuronal System—HRAS—skin cancer	4.46e-05	0.00355	CbGpPWpGaD
Miconazole—NOS3—SHP2 signaling—IL6—skin cancer	4.29e-05	0.00341	CbGpPWpGaD
Miconazole—NOS3—EGF/EGFR Signaling Pathway—BRAF—skin cancer	4.29e-05	0.00341	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.06e-05	0.00323	CbGpPWpGaD
Miconazole—KCNMA1—Neuronal System—BRAF—skin cancer	4e-05	0.00318	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—NRAS—skin cancer	3.79e-05	0.00301	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—NRAS—skin cancer	3.79e-05	0.00301	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—NRAS—skin cancer	3.79e-05	0.00301	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—NRAS—skin cancer	3.79e-05	0.00301	CbGpPWpGaD
Miconazole—NOS3—VEGFA-VEGFR2 Pathway—NRAS—skin cancer	3.75e-05	0.00298	CbGpPWpGaD
Miconazole—NOS2—Disease—CSPG4—skin cancer	3.67e-05	0.00291	CbGpPWpGaD
Miconazole—NOS3—Leptin signaling pathway—HRAS—skin cancer	3.65e-05	0.0029	CbGpPWpGaD
Miconazole—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	3.58e-05	0.00285	CbGpPWpGaD
Miconazole—NOS3—Signaling by VEGF—NRAS—skin cancer	3.54e-05	0.00282	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—PLIN2—skin cancer	3.51e-05	0.00279	CbGpPWpGaD
Miconazole—KCNH7—Circadian rythm related genes—TP53—skin cancer	3.48e-05	0.00277	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—TP53—skin cancer	3.42e-05	0.00272	CbGpPWpGaD
Miconazole—KCNN4—Neuronal System—HRAS—skin cancer	3.29e-05	0.00261	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—KRAS—skin cancer	3.26e-05	0.00259	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—KRAS—skin cancer	3.26e-05	0.00259	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—KRAS—skin cancer	3.26e-05	0.00259	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—KRAS—skin cancer	3.26e-05	0.00259	CbGpPWpGaD
Miconazole—NOS3—VEGFA-VEGFR2 Pathway—KRAS—skin cancer	3.23e-05	0.00257	CbGpPWpGaD
Miconazole—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	3.22e-05	0.00256	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—PLIN2—skin cancer	3.19e-05	0.00254	CbGpPWpGaD
Miconazole—KCNH7—Circadian rythm related genes—IL6—skin cancer	3.19e-05	0.00253	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—CDK4—skin cancer	3.14e-05	0.00249	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—IL6—skin cancer	3.13e-05	0.00249	CbGpPWpGaD
Miconazole—NOS3—Signaling by VEGF—KRAS—skin cancer	3.05e-05	0.00242	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—PLIN2—skin cancer	2.99e-05	0.00237	CbGpPWpGaD
Miconazole—NOS3—Metabolism—PLIN2—skin cancer	2.96e-05	0.00235	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—TP53—skin cancer	2.9e-05	0.0023	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—TP53—skin cancer	2.9e-05	0.0023	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—TP53—skin cancer	2.9e-05	0.0023	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—TP53—skin cancer	2.9e-05	0.0023	CbGpPWpGaD
Miconazole—KCNH6—Neuronal System—HRAS—skin cancer	2.87e-05	0.00228	CbGpPWpGaD
Miconazole—NOS3—Disease—CSPG4—skin cancer	2.85e-05	0.00226	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—CSPG4—skin cancer	2.83e-05	0.00225	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—skin cancer	2.77e-05	0.00221	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—HRAS—skin cancer	2.77e-05	0.0022	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—HRAS—skin cancer	2.77e-05	0.0022	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—HRAS—skin cancer	2.77e-05	0.0022	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—HRAS—skin cancer	2.77e-05	0.0022	CbGpPWpGaD
Miconazole—NOS3—VEGFA-VEGFR2 Pathway—HRAS—skin cancer	2.75e-05	0.00218	CbGpPWpGaD
Miconazole—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	2.63e-05	0.00209	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—PTCH2—skin cancer	2.63e-05	0.00209	CbGpPWpGaD
Miconazole—NOS3—VEGFA-VEGFR2 Pathway—IL6—skin cancer	2.63e-05	0.00209	CbGpPWpGaD
Miconazole—NOS3—Signaling by VEGF—HRAS—skin cancer	2.59e-05	0.00206	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—CSPG4—skin cancer	2.57e-05	0.00205	CbGpPWpGaD
Miconazole—KCNH7—Neuronal System—HRAS—skin cancer	2.56e-05	0.00204	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	2.53e-05	0.00201	CbGpPWpGaD
Miconazole—KCNMA1—Circadian rythm related genes—TP53—skin cancer	2.5e-05	0.00199	CbGpPWpGaD
Miconazole—NOS2—Disease—SHH—skin cancer	2.49e-05	0.00198	CbGpPWpGaD
Miconazole—NOS2—Disease—ENO2—skin cancer	2.49e-05	0.00198	CbGpPWpGaD
Miconazole—NOS3—Signaling by VEGF—IL6—skin cancer	2.48e-05	0.00197	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—CSPG4—skin cancer	2.41e-05	0.00191	CbGpPWpGaD
Miconazole—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	2.4e-05	0.00191	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.39e-05	0.0019	CbGpPWpGaD
Miconazole—NOS3—Metabolism—CSPG4—skin cancer	2.38e-05	0.00189	CbGpPWpGaD
Miconazole—KCNH2—Neuronal System—BRAF—skin cancer	2.36e-05	0.00188	CbGpPWpGaD
Miconazole—NOS3—EGF/EGFR Signaling Pathway—KRAS—skin cancer	2.32e-05	0.00184	CbGpPWpGaD
Miconazole—KCNMA1—Circadian rythm related genes—IL6—skin cancer	2.29e-05	0.00182	CbGpPWpGaD
Miconazole—NOS2—Circadian rythm related genes—TP53—skin cancer	2.23e-05	0.00178	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	2.19e-05	0.00174	CbGpPWpGaD
Miconazole—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	2.05e-05	0.00163	CbGpPWpGaD
Miconazole—NOS2—Circadian rythm related genes—IL6—skin cancer	2.04e-05	0.00162	CbGpPWpGaD
Miconazole—NOS2—Disease—FOXO4—skin cancer	2.03e-05	0.00161	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—GLI2—skin cancer	1.99e-05	0.00158	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.97e-05	0.00157	CbGpPWpGaD
Miconazole—NOS3—EGF/EGFR Signaling Pathway—HRAS—skin cancer	1.97e-05	0.00157	CbGpPWpGaD
Miconazole—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	1.95e-05	0.00155	CbGpPWpGaD
Miconazole—NOS3—Disease—ENO2—skin cancer	1.93e-05	0.00154	CbGpPWpGaD
Miconazole—NOS3—Disease—SHH—skin cancer	1.93e-05	0.00154	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—ENO2—skin cancer	1.92e-05	0.00153	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—MC1R—skin cancer	1.9e-05	0.00151	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—GLI1—skin cancer	1.87e-05	0.00149	CbGpPWpGaD
Miconazole—KCNMA1—Neuronal System—HRAS—skin cancer	1.84e-05	0.00146	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—PLIN2—skin cancer	1.81e-05	0.00144	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.8e-05	0.00143	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—SUFU—skin cancer	1.78e-05	0.00141	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—ENO2—skin cancer	1.75e-05	0.00139	CbGpPWpGaD
Miconazole—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.73e-05	0.00138	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	1.71e-05	0.00136	CbGpPWpGaD
Miconazole—KCNH2—SIDS Susceptibility Pathways—IL6—skin cancer	1.65e-05	0.00131	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—ENO2—skin cancer	1.64e-05	0.0013	CbGpPWpGaD
Miconazole—NOS3—Metabolism—ENO2—skin cancer	1.62e-05	0.00129	CbGpPWpGaD
Miconazole—NOS3—Disease—FOXO4—skin cancer	1.58e-05	0.00125	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—NRAS—skin cancer	1.56e-05	0.00124	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.54e-05	0.00122	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.51e-05	0.0012	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—skin cancer	1.5e-05	0.00119	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	1.47e-05	0.00117	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—CSPG4—skin cancer	1.46e-05	0.00116	CbGpPWpGaD
Miconazole—NOS2—Disease—ERCC2—skin cancer	1.45e-05	0.00115	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—PLIN2—skin cancer	1.44e-05	0.00115	CbGpPWpGaD
Miconazole—NOS2—Hemostasis—NRAS—skin cancer	1.39e-05	0.00111	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.37e-05	0.00109	CbGpPWpGaD
Miconazole—NOS2—Disease—TERT—skin cancer	1.36e-05	0.00108	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—SHH—skin cancer	1.35e-05	0.00108	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—RASA1—skin cancer	1.35e-05	0.00107	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—KRAS—skin cancer	1.34e-05	0.00107	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—skin cancer	1.33e-05	0.00106	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—SMO—skin cancer	1.28e-05	0.00102	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—PTCH1—skin cancer	1.28e-05	0.00102	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.28e-05	0.00102	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—PTGER4—skin cancer	1.25e-05	0.000994	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.25e-05	0.000993	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.23e-05	0.000979	CbGpPWpGaD
Miconazole—NOS2—Hemostasis—KRAS—skin cancer	1.2e-05	0.000954	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—TP53—skin cancer	1.19e-05	0.00095	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—PLIN2—skin cancer	1.16e-05	0.000924	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—CSPG4—skin cancer	1.16e-05	0.000923	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—HRAS—skin cancer	1.14e-05	0.000909	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—PLIN2—skin cancer	1.14e-05	0.000905	CbGpPWpGaD
Miconazole—NOS3—Disease—ERCC2—skin cancer	1.12e-05	0.000893	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—ERCC2—skin cancer	1.12e-05	0.000889	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—FOXO4—skin cancer	1.1e-05	0.000878	CbGpPWpGaD
Miconazole—KCNH2—Neuronal System—HRAS—skin cancer	1.08e-05	0.000862	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—NRAS—skin cancer	1.08e-05	0.000861	CbGpPWpGaD
Miconazole—NOS2—Disease—BRAF—skin cancer	1.07e-05	0.000854	CbGpPWpGaD
Miconazole—NOS2—Hemostasis—TP53—skin cancer	1.07e-05	0.000848	CbGpPWpGaD
Miconazole—NOS3—Disease—TERT—skin cancer	1.05e-05	0.000837	CbGpPWpGaD
Miconazole—NOS2—Hemostasis—HRAS—skin cancer	1.02e-05	0.000811	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—ERCC2—skin cancer	1.02e-05	0.000808	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—ENO2—skin cancer	9.91e-06	0.000788	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—ERCC2—skin cancer	9.51e-06	0.000756	CbGpPWpGaD
Miconazole—NOS3—Metabolism—ERCC2—skin cancer	9.41e-06	0.000748	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—CSPG4—skin cancer	9.37e-06	0.000745	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—KRAS—skin cancer	9.32e-06	0.000741	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—CSPG4—skin cancer	9.17e-06	0.000729	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	8.8e-06	0.000699	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—PLIN2—skin cancer	8.78e-06	0.000698	CbGpPWpGaD
Miconazole—NOS2—Disease—PTGS2—skin cancer	8.68e-06	0.00069	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—PLIN2—skin cancer	8.57e-06	0.000681	CbGpPWpGaD
Miconazole—NOS3—Disease—BRAF—skin cancer	8.34e-06	0.000663	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—TP53—skin cancer	8.28e-06	0.000659	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—PLIN2—skin cancer	8.08e-06	0.000642	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—PLIN2—skin cancer	8.01e-06	0.000637	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—HRAS—skin cancer	7.92e-06	0.00063	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—ENO2—skin cancer	7.89e-06	0.000627	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.75e-06	0.000617	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—TERT—skin cancer	7.38e-06	0.000586	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—CSPG4—skin cancer	7.08e-06	0.000563	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—CSPG4—skin cancer	6.91e-06	0.000549	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—PLIN2—skin cancer	6.84e-06	0.000544	CbGpPWpGaD
Miconazole—NOS2—Disease—NRAS—skin cancer	6.75e-06	0.000537	CbGpPWpGaD
Miconazole—NOS3—Disease—PTGS2—skin cancer	6.74e-06	0.000536	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—PTGS2—skin cancer	6.7e-06	0.000533	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—CSPG4—skin cancer	6.51e-06	0.000518	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—CSPG4—skin cancer	6.45e-06	0.000513	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—ENO2—skin cancer	6.37e-06	0.000506	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—ENO2—skin cancer	6.24e-06	0.000496	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—PTGS2—skin cancer	6.09e-06	0.000485	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	5.89e-06	0.000468	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—BRAF—skin cancer	5.84e-06	0.000464	CbGpPWpGaD
Miconazole—NOS2—Disease—KRAS—skin cancer	5.81e-06	0.000462	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—ERCC2—skin cancer	5.76e-06	0.000458	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—PTGS2—skin cancer	5.7e-06	0.000453	CbGpPWpGaD
Miconazole—NOS3—Metabolism—PTGS2—skin cancer	5.64e-06	0.000449	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—CSPG4—skin cancer	5.52e-06	0.000439	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—PLIN2—skin cancer	5.28e-06	0.00042	CbGpPWpGaD
Miconazole—NOS3—Disease—NRAS—skin cancer	5.24e-06	0.000417	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	5.23e-06	0.000416	CbGpPWpGaD
Miconazole—NOS2—Disease—HRAS—skin cancer	4.94e-06	0.000393	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—ENO2—skin cancer	4.81e-06	0.000383	CbGpPWpGaD
Miconazole—NOS2—Disease—IL6—skin cancer	4.73e-06	0.000376	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—ENO2—skin cancer	4.7e-06	0.000373	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—ERCC2—skin cancer	4.58e-06	0.000364	CbGpPWpGaD
Miconazole—NOS3—Disease—KRAS—skin cancer	4.51e-06	0.000359	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—ENO2—skin cancer	4.43e-06	0.000352	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—ENO2—skin cancer	4.39e-06	0.000349	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—CSPG4—skin cancer	4.26e-06	0.000338	CbGpPWpGaD
Miconazole—NOS3—Disease—HRAS—skin cancer	3.83e-06	0.000305	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.76e-06	0.000299	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—ENO2—skin cancer	3.75e-06	0.000298	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—ERCC2—skin cancer	3.7e-06	0.000294	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—NRAS—skin cancer	3.67e-06	0.000292	CbGpPWpGaD
Miconazole—NOS3—Disease—IL6—skin cancer	3.67e-06	0.000292	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—ERCC2—skin cancer	3.62e-06	0.000288	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—PTGS2—skin cancer	3.45e-06	0.000275	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.43e-06	0.000273	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—KRAS—skin cancer	3.16e-06	0.000251	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.93e-06	0.000233	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—ENO2—skin cancer	2.89e-06	0.00023	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—TP53—skin cancer	2.81e-06	0.000223	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—ERCC2—skin cancer	2.79e-06	0.000222	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—PTGS2—skin cancer	2.75e-06	0.000219	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—ERCC2—skin cancer	2.73e-06	0.000217	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—HRAS—skin cancer	2.69e-06	0.000214	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—ERCC2—skin cancer	2.57e-06	0.000204	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—IL6—skin cancer	2.57e-06	0.000204	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—ERCC2—skin cancer	2.55e-06	0.000203	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—PTGS2—skin cancer	2.22e-06	0.000176	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—ERCC2—skin cancer	2.18e-06	0.000173	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—PTGS2—skin cancer	2.17e-06	0.000173	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—ERCC2—skin cancer	1.68e-06	0.000134	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—PTGS2—skin cancer	1.68e-06	0.000133	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—PTGS2—skin cancer	1.64e-06	0.00013	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—PTGS2—skin cancer	1.54e-06	0.000123	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—PTGS2—skin cancer	1.53e-06	0.000121	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—PTGS2—skin cancer	1.31e-06	0.000104	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—PTGS2—skin cancer	1.01e-06	8.01e-05	CbGpPWpGaD
